• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤干细胞通过SOX2调节上调CD39表达以逃避免疫反应。

Glioma Stem Cells Upregulate CD39 Expression to Escape Immune Response through SOX2 Modulation.

作者信息

Liu Bin, Cao Yufei, Li Yanyan, Ma Haifeng, Yang Mingfei, Zhang Qiang, Li Guofeng, Zhang Kai, Wu Yue, Zhou Youxin, Yang Wei, Sun Ting

机构信息

Department of Neurosurgery, Laboratory of Brain and Nerve Research, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.

Department of Neurosurgery, Qinghai Provincial People's Hospital, Xining, Qinghai 810007, China.

出版信息

Cancers (Basel). 2022 Feb 3;14(3):783. doi: 10.3390/cancers14030783.

DOI:10.3390/cancers14030783
PMID:35159053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8834269/
Abstract

Ectonucleotidase CD39 hydrolyzing extracellular ATP (eATP) functions as a key modulator of immune response in the tumor microenvironment, yet the role of CD39 in contributing tumor stem cells in a more immunosuppressive microenvironment remains elusive. Here we report that the upregulation of CD39 is crucial for the decrease of extracellular ATP concentration around glioma stem cells (GSCs) to maintain an immunosuppressive microenvironment. Adriamycin (ADM) is able to promote the release of ATP, which recruits dendritic cells (DCs) to phagocytose GSCs. CD39 inhibition further increased extracellular ATP concentrations following ADM treatment and DCs phagocytosis. In addition, GSCs upregulated CD39 expression by SOX2-binding CD39 promotor. In mouse tumor models, the combination of ADM and CD39 blockade increased immune cell infiltration and reduced tumor size. These findings suggest that GSCs upregulate CD39 expression by their biological characteristics to maintain an immunosuppressive microenvironment, and CD39 inhibition supplies a favorable tumor microenvironment (TME) for immunotherapeutic intervention and enhances the immune response induced by chemotherapy.

摘要

胞外核苷酸酶CD39可水解细胞外ATP(eATP),在肿瘤微环境中作为免疫反应的关键调节因子发挥作用,然而CD39在更具免疫抑制性的微环境中对肿瘤干细胞形成的作用仍不清楚。在此我们报告,CD39的上调对于降低胶质瘤干细胞(GSCs)周围的细胞外ATP浓度以维持免疫抑制性微环境至关重要。阿霉素(ADM)能够促进ATP的释放,从而招募树突状细胞(DCs)来吞噬GSCs。CD39抑制作用在ADM处理和DCs吞噬后进一步增加了细胞外ATP浓度。此外,GSCs通过SOX2结合CD39启动子上调CD39表达。在小鼠肿瘤模型中,ADM与CD39阻断剂联合使用增加了免疫细胞浸润并减小了肿瘤大小。这些发现表明,GSCs通过其生物学特性上调CD39表达以维持免疫抑制性微环境,而CD39抑制为免疫治疗干预提供了有利的肿瘤微环境(TME),并增强了化疗诱导的免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/9f79a883575a/cancers-14-00783-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/9da44484cf7d/cancers-14-00783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/16afb8106b50/cancers-14-00783-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/bf8cbef6fd2e/cancers-14-00783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/d8b16821cab1/cancers-14-00783-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/db4727103cfa/cancers-14-00783-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/870e849c33b7/cancers-14-00783-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/9d01d9ccb08d/cancers-14-00783-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/9f79a883575a/cancers-14-00783-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/9da44484cf7d/cancers-14-00783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/16afb8106b50/cancers-14-00783-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/bf8cbef6fd2e/cancers-14-00783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/d8b16821cab1/cancers-14-00783-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/db4727103cfa/cancers-14-00783-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/870e849c33b7/cancers-14-00783-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/9d01d9ccb08d/cancers-14-00783-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/8834269/9f79a883575a/cancers-14-00783-g008.jpg

相似文献

1
Glioma Stem Cells Upregulate CD39 Expression to Escape Immune Response through SOX2 Modulation.胶质瘤干细胞通过SOX2调节上调CD39表达以逃避免疫反应。
Cancers (Basel). 2022 Feb 3;14(3):783. doi: 10.3390/cancers14030783.
2
Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors.AB598 的表征,一种用于治疗实体瘤的 CD39 酶抑制性抗体。
Mol Cancer Ther. 2024 Oct 1;23(10):1471-1482. doi: 10.1158/1535-7163.MCT-23-0865.
3
CD39 (ENTPD1) in tumors: a potential therapeutic target and prognostic biomarker.
Biomark Med. 2023 Jun;17(12):563-576. doi: 10.2217/bmm-2023-0202. Epub 2023 Sep 15.
4
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.SRF617 是一种强效的 CD39 抑制剂,具有免疫调节和抗肿瘤特性。
Immunohorizons. 2023 May 1;7(5):366-379. doi: 10.4049/immunohorizons.2200089.
5
Identification and characterization of ecto-nucleoside triphosphate diphosphohydrolase 1 (CD39) involved in regulating extracellular ATP-mediated innate immune responses in Japanese flounder (Paralichthys olivaceus).鉴定和表征参与调控日本牙鲆(Paralichthys olivaceus)细胞外 ATP 介导的固有免疫反应的外核苷酸三磷酸二磷酸水解酶 1(CD39)。
Mol Immunol. 2019 Aug;112:10-21. doi: 10.1016/j.molimm.2019.04.024. Epub 2019 May 7.
6
Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.血管 CD39/ENTPD1 通过清除细胞外三磷酸腺苷直接促进肿瘤细胞生长。
Neoplasia. 2011 Mar;13(3):206-16. doi: 10.1593/neo.101332.
7
Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism.完全人源化抗 CD39 抗体通过非竞争性变构机制强效抑制癌细胞中的 ATP 酶活性。
MAbs. 2020 Jan-Dec;12(1):1838036. doi: 10.1080/19420862.2020.1838036.
8
Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.CD39 外核苷酸酶在 ATLL 细胞上高度表达,负责其免疫抑制功能。
Leukemia. 2021 Jan;35(1):107-118. doi: 10.1038/s41375-020-0788-y. Epub 2020 Mar 20.
9
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.反义寡核苷酸靶向 CD39 可改善抗肿瘤 T 细胞免疫。
J Immunother Cancer. 2019 Mar 12;7(1):67. doi: 10.1186/s40425-019-0545-9.
10
The yin and yang functions of extracellular ATP and adenosine in tumor immunity.细胞外ATP和腺苷在肿瘤免疫中的阴阳功能。
Cancer Cell Int. 2020 Apr 7;20:110. doi: 10.1186/s12935-020-01195-x. eCollection 2020.

引用本文的文献

1
Immune checkpoints in immune response to glioma: two sides of the same coin.胶质瘤免疫反应中的免疫检查点:硬币的两面
Front Immunol. 2025 Aug 15;16:1639521. doi: 10.3389/fimmu.2025.1639521. eCollection 2025.
2
Extracellular Adenosine in Gastric Cancer: The Role of GCSCs.胃癌中的细胞外腺苷:胃肿瘤干细胞的作用
Int J Mol Sci. 2025 Aug 6;26(15):7594. doi: 10.3390/ijms26157594.
3
CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects.

本文引用的文献

1
Characterization of a new human astrocytoma cell line SHG140: cell proliferation, cell phenotype, karyotype, STR markers and tumorigenicity analysis.一种新的人星形细胞瘤细胞系SHG140的特性:细胞增殖、细胞表型、核型、STR标记及致瘤性分析
J Cancer. 2021 Jan 1;12(2):371-378. doi: 10.7150/jca.40802. eCollection 2021.
2
Targeting CD39 in cancer.针对癌症的 CD39 靶点。
Nat Rev Immunol. 2020 Dec;20(12):739-755. doi: 10.1038/s41577-020-0376-4. Epub 2020 Jul 29.
3
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.
基于嵌合抗原受体 T 淋巴细胞的细胞疗法;自杀基因在机制论证、应用和生物安全性增强方面的作用:消除副作用的新机遇。
Front Immunol. 2024 Jul 18;15:1333150. doi: 10.3389/fimmu.2024.1333150. eCollection 2024.
4
Cancer stem cells in brain tumors: From origin to clinical implications.脑肿瘤中的癌症干细胞:从起源到临床意义。
MedComm (2020). 2023 Aug 9;4(4):e341. doi: 10.1002/mco2.341. eCollection 2023 Aug.
5
Advances in research on immune escape mechanism of glioma.胶质瘤免疫逃逸机制研究进展。
CNS Neurosci Ther. 2023 Jul;29(7):1709-1720. doi: 10.1111/cns.14217. Epub 2023 Apr 23.
6
In lung adenocarcinoma, low expression of the cell surface extracellular nucleotidase CD39 is related to immune infiltration and a poor prognosis.在肺腺癌中,细胞表面胞外核苷酸酶CD39的低表达与免疫浸润及不良预后相关。
J Thorac Dis. 2022 Dec;14(12):4938-4950. doi: 10.21037/jtd-22-1696.
7
Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities.探索胶质母细胞瘤干细胞异质性:免疫微环境调节与治疗机遇。
Front Oncol. 2022 Sep 21;12:995498. doi: 10.3389/fonc.2022.995498. eCollection 2022.
在多发性骨髓瘤中,通过 CD39 和 CD73 将 ATP 转化为腺苷,可以与腺苷受体 A2A 阻断一起成功靶向。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000610.
4
A protocol for rapid monocyte isolation and generation of singular human monocyte-derived dendritic cells.一种快速分离单核细胞并生成单一人类单核细胞来源树突状细胞的方案。
PLoS One. 2020 Apr 9;15(4):e0231132. doi: 10.1371/journal.pone.0231132. eCollection 2020.
5
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.靶向肿瘤细胞 CD39 可揭示细胞外 ATP 与炎症小体驱动的肿瘤免疫。
Cancer Discov. 2019 Dec;9(12):1754-1773. doi: 10.1158/2159-8290.CD-19-0541. Epub 2019 Nov 7.
6
MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway.胶质瘤干细胞 MHC I 类分子功能障碍通过激活 Wnt/β-catenin 信号通路逃避 CTL 介导的免疫反应。
Oncogene. 2020 Jan;39(5):1098-1111. doi: 10.1038/s41388-019-1045-6. Epub 2019 Oct 7.
7
SOX2 in development and cancer biology.发育与癌症生物学中的SOX2
Semin Cancer Biol. 2020 Dec;67(Pt 1):74-82. doi: 10.1016/j.semcancer.2019.08.007. Epub 2019 Aug 11.
8
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.阻断针对 CD39/CD73 免疫抑制通路的抗体在联合癌症疗法中引发免疫反应。
Cell Rep. 2019 May 21;27(8):2411-2425.e9. doi: 10.1016/j.celrep.2019.04.091.
9
ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.三磷酸腺苷及其代谢物腺苷作为树突状细胞活性的调节剂。
Front Immunol. 2018 Nov 9;9:2581. doi: 10.3389/fimmu.2018.02581. eCollection 2018.
10
Dendritic Cell Assays.
Methods Mol Biol. 2018;1803:243-253. doi: 10.1007/978-1-4939-8549-4_16.